Europska Unija -
norveški -
EMA (European Medicines Agency)
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioødemer, arvelig - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
Norveška -
norveški -
Statens legemiddelverk
purimmun 50 mg
2care4 generics aps - merkaptopurin - tablett - 50 mg
Europska Unija -
norveški -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Norveška -
norveški -
Statens legemiddelverk
bupivacaine baxter 2.5 mg/ ml
baxter holding b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml
Norveška -
norveški -
Statens legemiddelverk
bupivacaine baxter 5 mg/ ml
baxter holding b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml
Europska Unija -
norveški -
EMA (European Medicines Agency)
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psykoleptika, hypnotika og sedativer - hunder - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
Europska Unija -
norveški -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Europska Unija -
norveški -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Europska Unija -
norveški -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Norveška -
norveški -
Statens legemiddelverk
alpramil vet 5 mg / 50 mg
alfasan nederland b.v. - milbemycinoksim / prazikvantel - tablett - 5 mg / 50 mg